Medivir strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant ...Middle East

News by : (PR Newswire) -
STOCKHOLM, Dec. 11, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announced today that Medivir AB ("Medivir" or "the Company") has renegotiated its agreement with TetraLogic Pharmaceuticals Corporation ("TetraLogic") regarding financial obligations for birinapant, a SMAC...

Hence then, the article about medivir strengthens its business development possibilities through a renegotiated agreement with tetralogic regarding birinapant was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medivir strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار